Megan Vignos

7PUBLICATIONS
21CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)VirologyPsychosocial aspects of childbirth and perinatal mental healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 16, 2025
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry.

Melissa A Wright, Bradley J Barney, Skyler Peterson

|Jul 15, 2025
Outcomes of older patients with multiple sclerosis treated with interferon beta-1a or peginterferon beta-1a in MS PATHS.

Le H Hua, Carrie M Hersh, Lana Zhovtis Ryerson

|May 24, 2024
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.

Marco Salvetti, Sibyl Wray, Gereon Nelles

|Sep 22, 2023
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX<sup>®</sup> Pregnancy Exposure Registry.

Bianca Weinstock-Guttman, Amy Perrin Ross, Jonathan Planton

|Sep 18, 2023
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey.

Hayrettin Tumani, Patricia K Coyle, Claudia Cárcamo

|Nov 18, 2021
Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.

Patricia K Coyle, Anne Gocke, Megan Vignos

Pageof 2